Clinical Trial Update: A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma

View source ↗

Summary

Pfizer conducted a study to evaluate the effectiveness of Elranatamab in relapsed or refractory multiple myeloma; the trial has completed and results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Elranatamab (elranatamab)

Snippet

Sponsor: Pfizer | Conditions: Multiple Myeloma | Status: COMPLETED | Results posted: 2024-10-29